Physician profile
Edward Salvatore Alessandrini
NPI 1881634533
$23,951.04
in general payments reported to CMS, 2019-2025
6 companies · $3,730 in 2025
The $3,730 reported for 2025 was more than what 94% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $65.70 · 2021: $329 · 2022: $2,752 · 2023: $12K · 2024: $4,655 · 2025: $3,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $6,493 · Food and Beverage: $2,705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,448.75 |
| Travel and Lodging | $6,492.85 |
| Food and Beverage | $2,704.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $23,230.05 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $266.24 | 2020-2021 | |
| Keystone Dental INC. | $249.01 | 2019-2021 | |
| Geistlich Pharma, North America, INC. | $99.71 | 2024-2025 | Geistlich Bio-Gide, Biomaterials |
| Straumann USA LLC | $73.96 | 2019-2025 | |
| Abbvie INC. | $32.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Alessandrini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.